Quell Therapeutics Limited
Clinical trials sponsored by Quell Therapeutics Limited, explained in plain language.
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-phase trial tests an experimental treatment called QEL-005 in 16 adults with two autoimmune diseases: diffuse cutaneous systemic sclerosis and difficult-to-treat rheumatoid arthritis. QEL-005 is made from a patient's own white blood cells, which are genetically modifie…
Phase: PHASE1, PHASE2 • Sponsor: Quell Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Scientists study immune cells to build better therapies for autoimmune diseases
Knowledge-focused Recruiting nowThis study collects and analyzes white blood cells from healthy volunteers and patients with autoimmune diseases, inflammation, or liver transplant. The goal is to understand these cells better so researchers can design engineered regulatory T cell (Treg) therapies. The study doe…
Sponsor: Quell Therapeutics Limited • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC